Mutations of the promoter region of TERT have been suggested to be a key terminal event in the evolution of glioblastomas, but it has an intriguing property of being mutated also in oligodendrogliomas, which are mostly low-grade gliomas (43). The gene discussed is TERT; the disease is central nervous system cancer.